181
Participants
Start Date
September 22, 2020
Primary Completion Date
April 30, 2022
Study Completion Date
June 3, 2022
Pradigastat Tablets 20mg
20mg, once daily, oral administration
Pradigastat Tablets 40mg
40mg, once daily, oral administration
Pradigastat Tablets 20mg matching Placebo
once daily, oral administration
Pradigastat Tablets 40mg matching Placebo
once daily, oral administration
PMG Research of Charleston, Mt. Pleasant
Evanston Premier Healthcare Research, Evanston
Long Island Gastrointestinal Research Group LLP, New York
Jubilee Clinical Research, Las Vegas
Advanced Clinical Research-Meridian, Meridian
Beijing Friendship Hospital, Capital Medical University, Beijing
Siping Central People's Hospital, Siping
Huashan Hospital Affiliated to Fudan University, Shanghai
Shanghai East Hospital, Shanghai
Nanjing First Hospital, Nanjing
Ruijin Hopsital, Shanghai
Affiliated Hospital of Jiangsu University, Suzhou
Huai'an First People's Hospital, Huai'an
Yangzhou First People's Hospital, Yangzhou
Sir Run Run Shaw Hospital Affiliated to Medical College of Zhejiang University, Hangzhou
The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou
Huzhou Central Hospital, Huzhou
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou
Pingxiang People's Hospital, Pingxiang
Quanzhou First Hospital, Quanzhou
The Third Xiangya Hospital of Central South University, Changsha
Renmin Hospital of Wuhan University, Wuhan
People's Hospital of Zhengzhou, Zhengzhou
Southern Medical University Nanfang Hospital, Guangzhou
The Second Hospital of Hebei Medical University, Shijiazhuang
Lead Sponsor
Collaborators (1)
Covance
INDUSTRY
Anji Pharma
INDUSTRY